Celgene Corporation (CELG): Today's Featured Health Care Winner

Celgene Corporation ( CELG) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.1%. By the end of trading, Celgene Corporation rose $1.35 (1.1%) to $120.26 on light volume. Throughout the day, 2,295,930 shares of Celgene Corporation exchanged hands as compared to its average daily volume of 3,133,800 shares. The stock ranged in a price between $118.93-$121.13 after having opened the day at $119.00 as compared to the previous trading day's close of $118.91. Other companies within the Health Care sector that increased today were: Ambit Biosciences ( AMBI), up 18.2%, Aoxing Pharmaceutical Company ( AXN), up 13.9%, Celldex Therapeutics ( CLDX), up 12.3% and Puma Biotechnology ( PBYI), up 12.3%.

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and immune-inflammatory related diseases in the United States, Europe, and other countries. Celgene Corporation has a market cap of $48.8 billion and is part of the drugs industry. The company has a P/E ratio of 35.6, above the S&P 500 P/E ratio of 17.7. Shares are up 51.5% year to date as of the close of trading on Monday. Currently there are 23 analysts that rate Celgene Corporation a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Celgene Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Pingtan Marine Enterprise ( PME), down 61.6%, Mast Therapeutics ( MSTX), down 39.8%, Achillion Pharmaceuticals ( ACHN), down 25.1% and SunLink Health Systems ( SSY), down 12.1% , were all laggards within the health care sector with Humana ( HUM) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Dow Tumbles as Trump Calls Off North Korea Summit

Dow Tumbles as Trump Calls Off North Korea Summit

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio